Sort
16,300 grants matching “fatty liver disease”
Complement factor H modulates lipoprotein clearance in AMD
$575,241Catherine Bowes Rickman · Duke University · R01 · FY2023 · EY
Complement factor H modulates lipoprotein clearance in AMD
$575,241Catherine Bowes Rickman · Duke University · R01 · FY2024 · EY
Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study
$575,175Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
NR4A Orphan Receptors And Insulin Resistance
$575,174W Timothy Garvey · University Of Alabama At Birmingham · R01 · FY2010 · DK
Understanding and targeting bone marrow microenvironment in myelofibrosis
$575,051Lei Ding · Columbia University Health Sciences · R01 · FY2021 · HL
Understanding and targeting bone marrow microenvironment in myelofibrosis
$575,051Lei Ding · Columbia University Health Sciences · R01 · FY2023 · HL
Understanding and targeting bone marrow microenvironment in myelofibrosis
$575,051Lei Ding · Columbia University Health Sciences · R01 · FY2022 · HL
Adipose MTP and FIT2 in the regulation of plasma lipids, obesity and atherosclerosis
$574,999M Mahmood Hussain · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2025 · HL
Quantitative MRI and Deep Learning Technologies for Classification of NAFLD
$574,875Holden H Wu · University Of California Los Angeles · U01 · FY2023 · EB
Regulation of Rhythmic m6A RNA Modification by ERâassociated Degradation
$574,804Kezhong Zhang · Wayne State University · R01 · FY2021 · DK
The molecular genetic analysis of human obesity
$574,702Rudolph L Leibel · Columbia University Health Sciences · R01 · FY2017 · DK
Outcome of NASH in Adolescents after Bariatric Surgery vs. Lifestyle Intervention
$574,508Stavra Xanthakos · Cincinnati Childrens Hosp Med Ctr · R01 · FY2014 · DK
Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention
$574,424Robert E Gerszten · Beth Israel Deaconess Medical Center · R01 · FY2022 · NR
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
$574,395Robert S Brown · Weill Medical Coll Of Cornell Univ · U01 · FY2022 · DK
North Carolina Center for Coastal Algae, People, and Environment (NC C-CAPE)
$574,296Astrid Schnetzer · North Carolina State University Raleigh · P01 · FY2025 · ES
Complement factor H modulates lipoprotein clearance in AMD
$574,114Catherine Bowes Rickman · Duke University · R01 · FY2020 · EY
Genomic, gene-environment and casual inference studies in diabetic complications
$574,076Rany Salem · University Of California, San Diego · R01 · FY2023 · DK
Role of Multi-enzyme Complex in ApoBCL Secretion
$574,000Jay D Horton · Ut Southwestern Medical Center · P01 · FY2022 · HL
Role of Multi-enzyme Complex in ApoBCL Secretion
$574,000Jay D Horton · Ut Southwestern Medical Center · P01 · FY2023 · HL
Post-translational Control of Triglyceride and Cholesterol Metabolism by ANGPTL3 & ANGPTL8 in ApoBCL Clearance
$574,000Helen H. Hobbs · Ut Southwestern Medical Center · P01 · FY2022 · HL
Post-translational Control of Triglyceride and Cholesterol Metabolism by ANGPTL3 & ANGPTL8 in ApoBCL Clearance
$574,000Helen H. Hobbs · Ut Southwestern Medical Center · P01 · FY2023 · HL
Understanding the metabolic pathology of pediatric obesity and NAFLD
$573,930Kevin R. Short · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · DK
Effect of Insulin and Propranolol on Post Burn Hypermetabolism and Inflammation
$573,916David N Herndon · University Of Texas Med Br Galveston · R01 · FY2011 · GM
Lipotoxicity and Maintenance of Metabolic Health
$573,863Jean E Schaffer · Joslin Diabetes Center · R01 · FY2024 · DK
Exosomes and insulin action in metabolically healthy and unhealthy obesity
$573,795Samuel Klein · Washington University · R01 · FY2023 · DK